Concepedia

Author

Annamaria Ferrero

University of TurinORCID

Also Known As

A FERRERO, A Ferrero, A M Ferrero, A. Dorum, A. Ferrero, A.M. Ferrero, AM FERRERO, ANNA MARIA FERRERO, ANNAMARIA FERRERO, Alessandro Ferrero

356

Publications

9.3K

Citations

47

H-Index

77

Concepts

All Affiliations

University of TurinA. O. Ordine Mauriziano di TorinoEuropean Institute of OncologyUniversity of PisaIstituti di Ricovero e Cura a Carattere Scientifico
AF

About

Annamaria Ferrero is an author at University of Turin specializing in medicine, oncology, and obstetrics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

41

3.7K

2

Health Sciences

3

3

91

3

Natural Sciences

1

1

62

4

Public Health

1

1

63

5

Biochemistry

1

1

62

Annamaria Ferrero

×

89

Publications

7.8K

Citations

43

H-Index

YearCitations

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo, Cristiana Sessa, Andreas du Bois,

Annals of Oncology

2019

1.1K

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin,

The Lancet Oncology

2018

599

Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

Éric Pujade-Lauraine, Uwe Wagner, Elisabeth Aavall-Lundqvist,

Journal of Clinical Oncology

2010

558

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin,

The Lancet Oncology

2019

432

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy

Marco Volante, Maria Pia Brizzi, Antongiulio Faggiano,

Modern Pathology

2007

320

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease

Michelle Wilson, Éric Pujade-Lauraine, Daisuke Aoki,

Annals of Oncology

2016

285

SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer

Luis Chiva, Vanna Zanagnolo, Denis Querleu,

International Journal of Gynecological Cancer

2020

284

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa,

The Lancet Oncology

2021

280

Patterns of recurrence in patients with squamous cell carcinoma of the vulva

T Maggino, Fabio Landoni, Enrico Sartori,

Cancer

2000

236

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García,

The Lancet

2023

175

Page 1